Neurosense Therapeutics Ltd is trading 5.1% down at $0.74 as a sharp risk-off move in the broader markets pressures small-cap biotech names.
- The decline extends a multi-day slide for the stock, which has retreated from $0.90 on May 27.
- There are no fresh company-specific headlines or filings today; the move aligns with the S&P 500 and Nasdaq both falling more than 1%.